BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 2174507)

  • 1. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
    Wess J; Bonner TI; Brann MR
    Mol Pharmacol; 1990 Dec; 38(6):872-7. PubMed ID: 2174507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers.
    Wess J; Bonner TI; Dörje F; Brann MR
    Mol Pharmacol; 1990 Oct; 38(4):517-23. PubMed ID: 2172767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.
    Maggio R; Vogel Z; Wess J
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3103-7. PubMed ID: 8385357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of the third cytoplasmic loop in muscarinic receptor dimerization.
    Maggio R; Barbier P; Fornai F; Corsini GU
    J Biol Chem; 1996 Dec; 271(49):31055-60. PubMed ID: 8940100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
    Candell LM; Yun SH; Tran LL; Ehlert FJ
    Mol Pharmacol; 1990 Nov; 38(5):689-97. PubMed ID: 2172776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
    Wess J; Gdula D; Brann MR
    Mol Pharmacol; 1992 Feb; 41(2):369-74. PubMed ID: 1538713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments.
    Maggio R; Vogel Z; Wess J
    FEBS Lett; 1993 Mar; 319(1-2):195-200. PubMed ID: 8454056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells.
    Eglen RM; Sharif NA; To ZP
    Eur J Pharmacol; 1993 Jan; 244(1):49-55. PubMed ID: 8420791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of porcine coronary muscarinic receptors.
    Entzeroth M; Doods HN; Mayer N
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):432-8. PubMed ID: 2366878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    Zhang LB; Horowitz B; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition.
    Baumgold J; White T
    Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
    Thomas EA; Baker SA; Ehlert FJ
    Mol Pharmacol; 1993 Jul; 44(1):102-10. PubMed ID: 8393516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of [3H]4-diphenylacetoxy-N-methylpiperidine methiodide to longitudinal ileal smooth muscle muscarinic receptors.
    Michel AD; Whiting RL
    Eur J Pharmacol; 1990 Feb; 176(2):197-205. PubMed ID: 2311667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses.
    Lee NH; Fryer AD; Forray C; el-Fakahany EE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):992-9. PubMed ID: 2557423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.